BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 8254151)

  • 1. Serotonin dysfunction syndromes: a functional common denominator for classification of depression, anxiety, and obsessive-compulsive disorder.
    Benkert O; Wetzel H; Szegedi A
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():3-14. PubMed ID: 8254151
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic potential of serotonin antagonists in depressive disorders.
    Wood MD; Thomas DR; Watson JM
    Expert Opin Investig Drugs; 2002 Apr; 11(4):457-67. PubMed ID: 11922855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonergic mechanisms and current and future psychiatric practice.
    Dubovsky SL; Thomas M
    J Clin Psychiatry; 1995; 56 Suppl 2():38-48. PubMed ID: 7844106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The place of obsessive compulsive disorder in the diagnostic hierarchy.
    Montgomery SA
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():19-23. PubMed ID: 1517551
    [No Abstract]   [Full Text] [Related]  

  • 5. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the serotonin reuptake inhibitors: rationales for the development of new serotonergic agents.
    Dubovsky SL
    J Clin Psychiatry; 1994 Feb; 55 Suppl():34-44. PubMed ID: 8077173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obsessive compulsive disorder is not an anxiety disorder.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Sep; 8 Suppl 1():57-62. PubMed ID: 8254154
    [No Abstract]   [Full Text] [Related]  

  • 8. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
    Saxena PR
    Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.
    Blier P; de Montigny C
    Biol Psychiatry; 1998 Sep; 44(5):313-23. PubMed ID: 9755353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin: la chica de moda in biological psychiatry?
    Banki CM
    Biol Psychiatry; 1991 May; 29(10):949-52. PubMed ID: 2065139
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin dysfunction disorders: a behavioral neurochemistry perspective.
    Petty F; Davis LL; Kabel D; Kramer GL
    J Clin Psychiatry; 1996; 57 Suppl 8():11-6. PubMed ID: 8698675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical utility of pharmacological agents that act at serotonin receptors.
    Peroutka SJ; Sleight AJ; McCarthy BG; Pierce PA; Schmidt AW; Hekmatpanah CR
    J Neuropsychiatry Clin Neurosci; 1989; 1(3):253-62. PubMed ID: 2562495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL; Pigott TA
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Animal models in obsessive compulsive disorder.
    Olivier B
    Int Clin Psychopharmacol; 1992 Jun; 7 Suppl 1():27-9. PubMed ID: 1517553
    [No Abstract]   [Full Text] [Related]  

  • 15. How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs.
    Goodwin GM
    J Clin Psychiatry; 1996; 57 Suppl 4():9-13. PubMed ID: 8636065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the therapeutic action of SSRI medications.
    Levine FJ
    J Am Psychoanal Assoc; 2004; 52(2):492-3; author reply 493-8. PubMed ID: 15222457
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects.
    Stahl SM
    J Affect Disord; 1998 Dec; 51(3):215-35. PubMed ID: 10333979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic mechanisms and the new antidepressants.
    Stahl SM
    Psychol Med; 1993 May; 23(2):281-5. PubMed ID: 8332642
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin in panic disorder and social phobia.
    Sheehan DV; Raj BA; Trehan RR; Knapp EL
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():63-77. PubMed ID: 7911142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anxiety--compulsiveness--depression. Symposium, Mainz, 8 May 1993].
    Nervenarzt; 1993 Sep; 64(9 Suppl):1-12. PubMed ID: 7477601
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.